SARS CoV 2 News and Research

RSS

Does the anti-influenza vaccination protect against SARS-CoV-2 infection?

Researchers performed a meta-analysis to evaluate the effect of influenza vaccination on SARS-CoV-2 infection.

2 Aug 2023

Does COVID-19 increase the risk of future gastrointestinal disorders?

Scientists review existing literature to examine the association between acute COVID-19 and the incidence of gastrointestinal symptoms.

2 Aug 2023

Antiviral protein protects against COVID-19 in live mouse models

A mammalian protein previously shown by UT Southwestern microbiologists to inhibit the virus that causes COVID-19 in cell culture also protected live mouse models, significantly limiting infection in the lung cells and diminishing the symptoms.

1 Aug 2023

Three doses of mRNA vaccine provide good protection for vulnerable people

Even vulnerable people, who are at risk of severe Covid-19, achieved good antibody levels after three doses of mRNA vaccine.

1 Aug 2023

New COVID-19 vaccine from HIPRA Human Health approved by MHRA

Bimervax, the COVID-19 vaccine developed by HIPRA Human Health, has today been authorized by the Medicines and Healthcare products Regulatory Agency (MHRA).

1 Aug 2023

New study spotlights effective strategy against COVID-19 variants: the E7 monoclonal antibody

Researchers developed potent monoclonal antibodies from a severe acute respiratory syndrome coronavirus (SARS-CoV) survivor.

1 Aug 2023

The long-term effects of SARS-CoV-2 infection on T cell activation: autoimmune disorders and endothelial cell dysfunction

Authors explored the impact of SARS-CoV-2 on thymus (T) cell activation.

1 Aug 2023

Novel algorithm characterizes RNA motifs in SARS-CoV and SARS-CoV-2

Researchers developed a novel algorithm to analyze large genomic datasets of RNA viruses, applying it to SARS-CoV-2 and SARS-CoV.

1 Aug 2023

Are wastewater surveillance metrics associated with high community case and hospitalization rates of COVID-19 across US counties?

Study aimed to understand whether the use of at-home COVID-19 tests impacted the determination of community-level incidence.

1 Aug 2023

Investigating the neurological effects of SARS-CoV-2: anosmia and neuroinvasion as separate phenomena

A group of researchers investigated the neurotropic potential of SARS-CoV-2 and its variants by studying their ability to invade the brain through the olfactory pathway in hamsters.

1 Aug 2023

Insights into the relationship between COVID-19 and mental health

Researchers investigated the causal consequences and genetic mechanisms that link the results of SARS-CoV-2 to anxiety disorders.

1 Aug 2023

SARS-CoV-2 spike pseudovirion infection in ARPE-19 cells is a dynamin-dependent process that is primarily mediated by LDLR

Researchers reported on lentiviral pseudovirions pseudotyped with SARS-CoV-2.

1 Aug 2023

Intranasal inoculation study sheds light on nasal and systemic immune responses to SARS-CoV-2

Study reveals the events accompanying the COVID-19 infection cascade in the nasal mucosa and free circulation

1 Aug 2023

New device can detect COVID-19 in less than a minute

Benjamin Sumlin, PhD, a senior scientist at Washington University in St. Louis, blows into a device designed by researchers at the university. The device — a breath test that uses a biosensor — could become a tool for use in doctors' offices to quickly diagnose people infected with the virus that causes COVID-19.

1 Aug 2023

NIH launches and opens enrollment for phase 2 clinical trials to evaluate long COVID treatments

Today, the National Institutes of Health launched and is opening enrollment for phase 2 clinical trials that will evaluate at least four potential treatments for long COVID, with additional clinical trials to test at least seven more treatments expected in the coming months.

31 Jul 2023

SARS CoV 2 News and Research

Does the anti-influenza vaccination protect against SARS-CoV-2 infection?

Does COVID-19 increase the risk of future gastrointestinal disorders?

Antiviral protein protects against COVID-19 in live mouse models

Three doses of mRNA vaccine provide good protection for vulnerable people

New COVID-19 vaccine from HIPRA Human Health approved by MHRA

New study spotlights effective strategy against COVID-19 variants: the E7 monoclonal antibody

The long-term effects of SARS-CoV-2 infection on T cell activation: autoimmune disorders and endothelial cell dysfunction

Novel algorithm characterizes RNA motifs in SARS-CoV and SARS-CoV-2

Are wastewater surveillance metrics associated with high community case and hospitalization rates of COVID-19 across US counties?

Investigating the neurological effects of SARS-CoV-2: anosmia and neuroinvasion as separate phenomena

Insights into the relationship between COVID-19 and mental health

SARS-CoV-2 spike pseudovirion infection in ARPE-19 cells is a dynamin-dependent process that is primarily mediated by LDLR

Intranasal inoculation study sheds light on nasal and systemic immune responses to SARS-CoV-2

New device can detect COVID-19 in less than a minute

NIH launches and opens enrollment for phase 2 clinical trials to evaluate long COVID treatments

Revolutionizing COVID-19 ARDS prediction: a deep learning model for critically ill patients

The incidence of diabetes following mRNA, inactivated COVID-19 vaccines, and after SARS-CoV-2 infection

The impact of COVID-19 on healthcare providers' attitudes towards self-care

Study shows that COVID-19 patients presented different plasma trace elements levels depending on disease severity

Is COVID-19 vaccination protective against thrombotic complications?

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Latest News